<DOC>
	<DOCNO>NCT01063920</DOCNO>
	<brief_summary>LT-NS001 prodrug Naproxen , inactive cox inhibitor intact rapidly metabolize Naproxen absorb . This trial compare rate gastric ulcer endoscopy three month patient knee osteoarthritis , patient receive either LT-NS001 dose provide comparable dose level Naproxen , Naprosyn速 500mg ( approve treatment OA ) .</brief_summary>
	<brief_title>Rates Gastric Ulcer Endoscopy Knee Osteoarthritis Patients Receiving LT-NS001 Versus Naprosyn速</brief_title>
	<detailed_description>This double-blind , double-dummy , active-comparator study LT-NS001 versus Naprosyn速 12 week patient age 45-80 osteoarthritis knee candidate ongoing NSAID therapy . The percentage patient gastric ulcer endoscopy ( EGD ) week 12 compare . EGD perform screening month 1 , 2 , 3 . Secondary objective include assessment pain affect knee WOMAC questionnaire demonstrate non-inferior pain control use LT-NS001 compare Naprosyn速 . Information gastrointestinal pain tolerability collect . The length study 19 week 2-3 week screen period , 12 week treatment period 4 week post treatment monitoring period .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Stomach Ulcer</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Osteoarthritis knee Appropriate candidate chronic NSAID therapy due moderate severe pain day 28 day screen study . Pregnant/Nursing woman History GI bleeding , perforation obstruction A document symptomatic GI ulcer past 5 year Presence GI ulcer 2 erosion screen endoscopy Allergy naproxen ( naproxen intolerance ) , acetylsalicylic acid , NSAID drug</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>LT-NS001</keyword>
	<keyword>Gastric Ulcers</keyword>
	<keyword>NSAID</keyword>
	<keyword>Osteoarthritis</keyword>
	<keyword>Naproxen</keyword>
</DOC>